Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Peptide analogs capable of enhancing stimulation of a glioma-specific CTL response

Peptide analogs capable of enhancing stimulation of a glioma-specific CTL response

US Patent 11723963 · Granted Aug 15, 2023

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods of treating EGFRvIII expressing glioblastomas2024
Methods of treating glioblastomas2024
H3.3 CTL peptides and uses thereof2024
Treatment of cancer using humanized anti-EGFRvIII chimeric antigen receptor2024
EphA2 T-cell epitope agonists and uses therefore2023
H3.3 CTL peptides and uses thereof2021
Methods for treating brain cancer using il-13r alpha 2 peptide-based composition2020
H3.3 CTL peptides and uses thereof2020
EPHA2 t-cell epitope agonists and uses therefore2020
Method for treating brain tumors2020
H3.3 CTL peptides and uses thereof2019
Peptide analogs capable of enhancing stimulation of a glioma-specific CTL respon2019